Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
Add more filters










Publication year range
1.
Mov Disord ; 37(10): 2033-2044, 2022 10.
Article in English | MEDLINE | ID: mdl-35989519

ABSTRACT

BACKGROUND: Lewy body diseases (LBDs), which are pathologically defined as the presence of intraneuronal α-synuclein (α-Syn) inclusions called Lewy bodies, encompass Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. Autopsy studies have shown that the olfactory bulb (OB) is one of the regions where Lewy pathology develops and initiates its spread in the brain. OBJECTIVE: This study aims to clarify how Lewy pathology spreads from the OB and affects brain functions using nonhuman primates. METHODS: We inoculated α-Syn preformed fibrils into the unilateral OBs of common marmosets (Callithrix jacchus) and performed pathological analyses, manganese-enhanced magnetic resonance imaging, and 18 F-fluoro-2-deoxy-d-glucose positron emission tomography up to 6 months postinoculation. RESULTS: Severe α-Syn pathology was observed within the olfactory pathway and limbic system, while mild α-Syn pathology was seen in a wide range of brain regions, including the substantia nigra pars compacta, locus coeruleus, and even dorsal motor nucleus of the vagus nerve. The brain imaging analyses showed reduction in volume of the OB and progressive glucose hypometabolism in widespread brain regions, including the occipital lobe, and extended beyond the pathologically affected regions. CONCLUSIONS: We generated a novel nonhuman primate LBD model with α-Syn propagation from the OB. This model suggests that α-Syn propagation from the OB is related to OB atrophy and cerebral glucose hypometabolism in LBDs. © 2022 International Parkinson and Movement Disorder Society.


Subject(s)
Lewy Body Disease , Parkinson Disease , Animals , Callithrix/metabolism , Deoxyglucose/metabolism , Glucose/metabolism , Lewy Body Disease/pathology , Manganese/metabolism , Olfactory Bulb/metabolism , Parkinson Disease/metabolism , alpha-Synuclein/metabolism
2.
Neurosci Lett ; 765: 136267, 2021 11 20.
Article in English | MEDLINE | ID: mdl-34571089

ABSTRACT

For the development of disease-modifying therapies for Parkinson's disease (PD) the identification of biomarkers in the prodromal stage is urgently required. Because PD is considered a systemic disease even in the early stage, we performed a metabolomic analysis of the plasma from a mouse model of prodromal PD (p-PD). Increased levels of isobutyrylcarnitine in p-PD mice imply an abnormality in ß-oxidation in mitochondria, and increased levels of pyrimidine nucleoside can be associated with mitochondrial dysfunction. Consistent with these results, the immunoblot analysis showed a defect in mitochondrial complex I assembly in p-PD mice. These results suggest that systemic mitochondrial dysfunction may exist in p-PD mice and contribute to the pathogenesis of PD, potentially being useful as early biomarkers for PD.


Subject(s)
Biomarkers/blood , Carnitine/analogs & derivatives , Mitochondria/pathology , Parkinsonian Disorders/metabolism , Animals , Carnitine/blood , Disease Models, Animal , Metabolomics , Mice , Mitochondria/metabolism , Prodromal Symptoms
3.
Biomed Res Int ; 2021: 7727648, 2021.
Article in English | MEDLINE | ID: mdl-35005021

ABSTRACT

Retinal degeneration is a progressive retinal damage in ocular vascular diseases. There are several reasons for this, such as occlusion of arteries or veins, diabetic retinopathy, or hereditary retinal diseases. To study pathological mechanisms of retinal degeneration, it is required to develop experimentally reproducible and clinically relevant models. In our previous studies, we developed a murine model of retinal hypoperfusion by unilateral common carotid artery occlusion (UCCAO) which mimics the pathophysiology of ocular ischemic syndrome (OIS) in humans, and described broad pathological mechanisms in the retina after UCCAO. However, there still remain missing pieces of the ocular pathologic process by UCCAO. In this study, we examined those unfound mechanisms. UCCAO was performed on adult mice. Ocular dysfunctions, histological deficits, and inflammation were examined after UCCAO, compared with sham-operated mice. Evaluation values were analyzed by electrophysiological, histological, and molecular biological methods. Eyelid drooping was permanently seen after UCCAO. Induction time point of acute reversible cataract under anesthesia was shortened. Retinal/visual dysfunctions were detected 2-4 weeks after UCCAO. Specifically, scotopic b-wave was more affected than a-wave, with the dysfunction of photopic b-wave. Impaired oscillatory potentials and visual evoked potential were constantly observed. Pathological Müller gliosis/inflammation was featured with NeuN-positive cell loss in the ganglion cell layer. Axial length, intraocular pressure, pupillary light reflex, and retinal pigment epithelium/choroidal thickness were not changed by UCCAO. A murine model of retinal ischemia by UCCAO can be useful for studying a series of degenerative process in the ischemic retina.


Subject(s)
Arterial Occlusive Diseases/pathology , Carotid Artery Diseases/pathology , Carotid Artery, Common/pathology , Ischemia/pathology , Retina/pathology , Retinal Degeneration/pathology , Animals , Disease Models, Animal , Evoked Potentials, Visual/physiology , Male , Mice , Mice, Inbred C57BL , Retinal Ganglion Cells/pathology
4.
Brain ; 143(1): 249-265, 2020 01 01.
Article in English | MEDLINE | ID: mdl-31816026

ABSTRACT

Parkinson's disease is one of the most common movement disorders and is characterized by dopaminergic cell loss and the accumulation of pathological α-synuclein, but its precise pathogenetic mechanisms remain elusive. To develop disease-modifying therapies for Parkinson's disease, an animal model that recapitulates the pathology and symptoms of the disease, especially in the prodromal stage, is indispensable. As subjects with α-synuclein gene (SNCA) multiplication as well as point mutations develop familial Parkinson's disease and a genome-wide association study in Parkinson's disease has identified SNCA as a risk gene for Parkinson's disease, the increased expression of α-synuclein is closely associated with the aetiology of Parkinson's disease. In this study we generated bacterial artificial chromosome transgenic mice harbouring SNCA and its gene expression regulatory regions in order to maintain the native expression pattern of α-synuclein. Furthermore, to enhance the pathological properties of α-synuclein, we inserted into SNCA an A53T mutation, two single-nucleotide polymorphisms identified in a genome-wide association study in Parkinson's disease and a Rep1 polymorphism, all of which are causal of familial Parkinson's disease or increase the risk of sporadic Parkinson's disease. These A53T SNCA bacterial artificial chromosome transgenic mice showed an expression pattern of human α-synuclein very similar to that of endogenous mouse α-synuclein. They expressed truncated, oligomeric and proteinase K-resistant phosphorylated forms of α-synuclein in the regions that are specifically affected in Parkinson's disease and/or dementia with Lewy bodies, including the olfactory bulb, cerebral cortex, striatum and substantia nigra. Surprisingly, these mice exhibited rapid eye movement (REM) sleep without atonia, which is a key feature of REM sleep behaviour disorder, at as early as 5 months of age. Consistent with this observation, the REM sleep-regulating neuronal populations in the lower brainstem, including the sublaterodorsal tegmental nucleus, nuclei in the ventromedial medullary reticular formation and the pedunculopontine nuclei, expressed phosphorylated α-synuclein. In addition, they also showed hyposmia at 9 months of age, which is consistent with the significant accumulation of phosphorylated α-synuclein in the olfactory bulb. The dopaminergic neurons in the substantia nigra pars compacta degenerated, and their number was decreased in an age-dependent manner by up to 17.1% at 18 months of age compared to wild-type, although the mice did not show any related locomotor dysfunction. In conclusion, we created a novel mouse model of prodromal Parkinson's disease that showed RBD-like behaviour and hyposmia without motor symptoms.


Subject(s)
Brain/metabolism , Disease Models, Animal , Mice , Olfaction Disorders/genetics , Parkinson Disease/genetics , Prodromal Symptoms , REM Sleep Behavior Disorder/genetics , alpha-Synuclein/genetics , Animals , Cell Count , Chromosomes, Artificial, Bacterial , Electroencephalography , Electromyography , Endopeptidase K/metabolism , Mice, Transgenic , Olfaction Disorders/physiopathology , Parkinson Disease/physiopathology , Polymorphism, Single Nucleotide , REM Sleep Behavior Disorder/physiopathology , Sleep , alpha-Synuclein/metabolism
5.
Mol Neurodegener ; 14(1): 31, 2019 Jul 26.
Article in English | MEDLINE | ID: mdl-31349849

ABSTRACT

The original article [1] mistakenly omitted essential information regarding Fig. 1c; thus, the authors would like to note that Fig. 1c describes transmission electron microscopy of α-Syn PFFs before sonication.

6.
Hum Mol Genet ; 28(11): 1894-1904, 2019 06 01.
Article in English | MEDLINE | ID: mdl-30689867

ABSTRACT

Parkinson's disease (PD) is characterized by dopaminergic (DA) cell loss and the accumulation of pathological alpha synuclein (asyn), but its precise pathomechanism remains unclear, and no appropriate animal model has yet been established. Recent studies have shown that a heterozygous mutation of glucocerebrosidase (gba) is one of the most important genetic risk factors in PD. To create mouse model for PD, we crossed asyn Bacterial Artificial Chromosome transgenic mice with gba heterozygous knockout mice. These double-mutant (dm) mice express human asyn in a physiological manner through its native promoter and showed an increase in phosphorylated asyn in the regions vulnerable to PD, such as the olfactory bulb and dorsal motor nucleus of the vagus nerve. Only dm mice showed a significant reduction in DA cells in the substantia nigra pars compacta, suggesting these animals were suitable for a prodromal model of PD. Next, we investigated the in vivo mechanism by which GBA insufficiency accelerates PD pathology, focusing on lipid metabolism. Dm mice showed an increased level of glucosylsphingosine without any noticeable accumulation of glucosylceramide, a direct substrate of GBA. In addition, the overexpression of asyn resulted in decreased GBA activity in mice, while dm mice tended to show an even further decreased level of GBA activity. In conclusion, we created a novel prodromal mouse model to study the disease pathogenesis and develop novel therapeutics for PD and also revealed the mechanism by which heterozygous gba deficiency contributes to PD through abnormal lipid metabolism under conditions of an altered asyn expression in vivo.


Subject(s)
Glucosylceramidase/genetics , Parkinson Disease/genetics , alpha-Synuclein/genetics , Animals , Disease Models, Animal , Dopaminergic Neurons/metabolism , Dopaminergic Neurons/pathology , Humans , Lipid Metabolism/genetics , Mice , Mice, Knockout , Mice, Transgenic , Parkinson Disease/metabolism , Parkinson Disease/pathology , Pars Compacta/metabolism , Pars Compacta/pathology , Prodromal Symptoms
7.
Mol Neurodegener ; 13(1): 21, 2018 05 11.
Article in English | MEDLINE | ID: mdl-29751824

ABSTRACT

BACKGROUND: Intraneuronal α-synuclein (α-Syn) aggregates known as Lewy bodies (LBs) and the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) are the pathological hallmarks of Parkinson's disease (PD). Braak's hypothesis based on autopsy studies suggests that Lewy pathology initially occurs in the enteric nervous system (ENS) and then travels retrogradely to the dorsal motor nucleus of the vagus nerve (dmX), proceeding from there in a caudo-rostral direction. Recent evidence that α-Syn aggregates propagate between interconnected neurons supports this hypothesis. However, there is no direct evidence demonstrating this transmission from the ENS to the dmX and then to the SNpc. METHODS: We inoculated α-Syn preformed fibrils (PFFs) or phosphate-buffered saline (PBS) into the mouse gastric wall and analyzed the progression of the pathology. RESULTS: The mice inoculated with α-Syn PFFs, but not with PBS, developed phosphorylated α-Syn (p-α-Syn)-positive LB-like aggregates in the dmX at 45 days postinoculation. This aggregate formation was completely abolished when vagotomy was performed prior to inoculation of α-Syn PFFs, suggesting that the aggregates in the dmX were retrogradely induced via the vagus nerve. Unexpectedly, the number of neurons containing p-α-Syn-positive aggregates in the dmX decreased over time, and no further caudo-rostral propagation beyond the dmX was observed up to 12 months postinoculation. P-α-Syn-positive aggregates were also present in the myenteric plexus at 12 months postinoculation. However, unlike in patients with PD, there was no cell-type specificity in neurons containing those aggregates in this model. CONCLUSIONS: These results indicate that α-Syn PFF inoculation into the mouse gastrointestinal tract can induce α-Syn pathology resembling that of very early PD, but other factors are apparently required if further progression of PD pathology is to be replicated in this animal model.


Subject(s)
Brain Stem/pathology , Gastrointestinal Tract/metabolism , Vagus Nerve/metabolism , alpha-Synuclein/metabolism , Animals , Lewy Bodies/pathology , Male , Mice , Mice, Inbred C57BL , Parkinson Disease , Protein Transport/physiology
8.
Front Neurosci ; 11: 35, 2017.
Article in English | MEDLINE | ID: mdl-28220059

ABSTRACT

Adverse maternal environment during gestation and lactation can have negative effects on the developing brain that persist into adulthood and result in behavioral impairment. Recent studies of human and animal models suggest epidemiological and experimental association between disturbances in maternal environments during brain development and the occurrence of neuropsychiatric disorders, including autism spectrum disorder, attention deficit hyperactivity disorder, schizophrenia, anxiety, depression, and neurodegenerative diseases. In this review, we summarize recent advances in understanding the effects of maternal metabolic and hormonal abnormalities on the developing brain by focusing on the dynamics of dendritic spine, an excitatory postsynaptic structure. We discuss the abnormal instability of dendritic spines that is common to developmental disorders and neurological diseases. We also introduce our recent studies that demonstrate how maternal obesity and hyperandrogenism leads to abnormal development of neuronal circuitry and persistent synaptic instability, which results in the loss of synapses. The aim of this review is to highlight the links between abnormal maternal environment, behavioral impairment in offspring, and the dendiric spine pathology of neuropsychiatric disorders.

9.
Neurochem Int ; 97: 99-108, 2016 07.
Article in English | MEDLINE | ID: mdl-26970392

ABSTRACT

Maternal obesity has negative effects on the neurodevelopment of the offspring. Pups from high-fat diet (HFD)-fed mice exhibit peroxidized lipid accumulations in the brain and behavioral impairments. However, the synaptic basis of maternal HFD-induced brain dysfunction in offspring remains unclear. In the present study, we focused on the dynamics and morphology of postsynaptic dendritic spines and filopodia in the offspring of HFD-fed mouse dams, using in vivo two-photon imaging, chosen because of the involvement of peripheral organs and non-neuronal cells in the abnormal metabolic state. We observed instability of dendritic spines and filopodia in the cerebral cortex of offspring from HFD-fed dams. Interestingly, the synaptic instability persisted into adulthood with a lower spine density even when the offspring were fed with a normal diet after weaning. HFD-fed offspring from HFD-fed dams showed a severe disruption of dendritic spines. Synaptic instability and loss of spines were caused even by HFD exposure exclusively during lactation. The treatment of ascorbic acid, an antioxidant, during lactation ameliorated the synaptic impairments. These results suggest that maternal obesity leads to persistent synaptic impairments in the offspring, which may be associated with behavioral deficits in adulthood, and that these synaptic deficits may be due to oxidative stress from peroxidized lipid accumulations during the lactation period.


Subject(s)
Diet, High-Fat/adverse effects , Lactation/metabolism , Oxidative Stress/physiology , Prenatal Exposure Delayed Effects/metabolism , Synapses/metabolism , Animals , Dendritic Spines/metabolism , Dendritic Spines/pathology , Diet, High-Fat/trends , Female , Mice , Mice, Inbred C57BL , Mice, Transgenic , Pregnancy , Prenatal Exposure Delayed Effects/etiology , Prenatal Exposure Delayed Effects/pathology , Synapses/pathology
10.
Sci Rep ; 5: 16102, 2015 Nov 04.
Article in English | MEDLINE | ID: mdl-26531852

ABSTRACT

Late-onset neurodegenerative diseases are characterized by neurological symptoms and progressive neuronal death. Accumulating evidence suggests that neuronal dysfunction, rather than neuronal death, causes the symptoms of neurodegenerative diseases. However, the mechanisms underlying the dysfunction that occurs prior to cell death remain unclear. To investigate the synaptic basis of this dysfunction, we employed in vivo two-photon imaging to analyse excitatory postsynaptic dendritic protrusions. We used Sca1(154Q/2Q) mice, an established knock-in mouse model of the polyglutamine disease spinocerebellar ataxia type 1 (SCA1), which replicates human SCA1 features including ataxia, cognitive impairment, and neuronal death. We found that Sca1(154Q/2Q) mice exhibited greater synaptic instability than controls, without synaptic loss, in the cerebral cortex, where obvious neuronal death is not observed, even before the onset of distinct symptoms. Interestingly, this abnormal synaptic instability was evident in Sca1(154Q/2Q) mice from the synaptic developmental stage, and persisted into adulthood. Expression of synaptic scaffolding proteins was also lower in Sca1(154Q/2Q) mice than controls before synaptic maturation. As symptoms progressed, synaptic loss became evident. These results indicate that aberrant synaptic instability, accompanied by decreased expression of scaffolding proteins during synaptic development, is a very early pathology that precedes distinct neurological symptoms and neuronal cell death in SCA1.


Subject(s)
Ataxin-1/genetics , Spinocerebellar Ataxias/pathology , Synapses/metabolism , Animals , Ataxin-1/metabolism , CA1 Region, Hippocampal/metabolism , CA1 Region, Hippocampal/pathology , Cerebral Cortex/metabolism , Dendrites/metabolism , Dendrites/pathology , Disease Models, Animal , Gene Knock-In Techniques , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Confocal , Microscopy, Fluorescence, Multiphoton , Nuclear Proteins/metabolism , Spinocerebellar Ataxias/metabolism , Time Factors
11.
Horm Behav ; 74: 149-56, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26122288

ABSTRACT

This article is part of a Special Issue "Estradiol and cognition". Estradiol (E2) is locally synthesized within the hippocampus and the gonads. Rapid modulation of hippocampal synaptic plasticity by E2 is essential for synaptic regulation. The molecular mechanisms of modulation through the synaptic estrogen receptor (ER) and its downstream signaling, however, are largely unknown in the dentate gyrus (DG). We investigated the E2-induced modulation of dendritic spines in male adult rat hippocampal slices by imaging Lucifer Yellow-injected DG granule cells. Treatments with 1 nM E2 increased the density of spines by approximately 1.4-fold within 2h. Spine head diameter analysis showed that the density of middle-head spines (0.4-0.5 µm) was significantly increased. The E2-induced spine density increase was suppressed by blocking Erk MAPK, PKA, PKC and LIMK. These suppressive effects by kinase inhibitors are not non-specific ones because the GSK-3ß antagonist did not inhibit E2-induced spine increase. The ER antagonist ICI 182,780 also blocked the E2-induced spine increase. Taken together, these results suggest that E2 rapidly increases the density of spines through kinase networks that are driven by synaptic ER.


Subject(s)
Dendritic Spines/physiology , Dentate Gyrus/cytology , Estradiol/physiology , Protein Kinases/physiology , Animals , Cell Count , Dendritic Spines/drug effects , Dentate Gyrus/drug effects , Estradiol/analogs & derivatives , Estradiol/pharmacology , Estrogen Receptor Antagonists/pharmacology , Fulvestrant , Male , Metabolic Networks and Pathways/drug effects , Neuronal Plasticity/drug effects , Neuronal Plasticity/physiology , Rats , Rats, Wistar
12.
Neurochem Int ; 85-86: 53-8, 2015.
Article in English | MEDLINE | ID: mdl-25953664

ABSTRACT

Fetal brain development is programmed by the maternal intrauterine environment, and disturbance of the in utero environment leads to persisting deficits in brain functions of the offspring. Testosterone is an intrauterine environmental factor, and plays significant roles in fetal development. From human and animal model studies, it has been suggested that increased intrauterine testosterone concentration triggers subsequent autistic-like behavior of the offspring; however, the effects of maternal excess testosterone on synaptic development of the offspring remain unknown. In the present study, we employed prenatally testosterone-exposed mice, and by using in vivo two-photon imaging, we analyzed the dynamics, density, and morphology of the dendritic spine, an excitatory postsynaptic structure. We found that the offspring from testosterone-treated dams showed abnormal synaptic instability persisting into young adulthood, whereas dendritic spines in control mice became stabilized with normal synaptic maturation. In prenatally testosterone-exposed mice, the density of dendritic spines was excessively increased, and their morphology was abnormal. These results suggest that prenatally testosterone-exposed mice may have deficits in synaptic development, and furthermore that the observed pathological features of their dendritic spines may be the cause of the synaptic pathogenesis in prenatally testosterone-exposed mice.


Subject(s)
Dendritic Spines/pathology , Prenatal Exposure Delayed Effects , Testosterone/administration & dosage , Animals , Female , Mice , Mice, Inbred C57BL , Pregnancy
13.
Brain Res ; 1621: 121-32, 2015 Sep 24.
Article in English | MEDLINE | ID: mdl-25511993

ABSTRACT

Rapid modulation of hippocampal synaptic plasticity by locally synthesized androgen is important in addition to circulating androgen. Here, we investigated the rapid changes of dendritic spines in response to the elevation of dihydrotestosterone (DHT) and testosterone (T), by using hippocampal slices from adult male rats, in order to clarify whether these signaling processes include synaptic/extranuclear androgen receptor (AR) and activation of kinases. We found that the application of 10nM DHT and 10nM T increased the total density of spines by approximately 1.3-fold within 2h, by imaging Lucifer Yellow-injected CA1 pyramidal neurons. Interestingly, DHT and T increased different head-sized spines. While DHT increased middle- and large-head spines, T increased small-head spines. Androgen-induced spinogenesis was suppressed by individually blocking Erk MAPK, PKA, PKC, p38 MAPK, LIMK or calcineurin. On the other hand, blocking CaMKII did not inhibit spinogenesis. Blocking PI3K altered the spine head diameter distribution, but did not change the total spine density. Blocking mRNA and protein synthesis did not suppress the enhancing effects induced by DHT or T. The enhanced spinogenesis by androgens was blocked by AR antagonist, which AR was localized postsynaptically. Taken together, these results imply that enhanced spinogenesis by DHT and T is mediated by synaptic/extranuclear AR which rapidly drives the kinase networks. This article is part of a Special Issue entitled SI: Brain and Memory.


Subject(s)
Androgens/physiology , CA1 Region, Hippocampal/physiology , Dendritic Spines/physiology , Dihydrotestosterone/pharmacology , Synapses/physiology , Testosterone/physiology , Androgens/pharmacology , Animals , CA1 Region, Hippocampal/cytology , CA1 Region, Hippocampal/drug effects , Dendritic Spines/drug effects , MAP Kinase Signaling System , Male , Rats , Rats, Wistar , Receptors, Androgen/physiology , Synapses/drug effects , Testosterone/pharmacology
14.
J Biol Chem ; 290(3): 1442-53, 2015 Jan 16.
Article in English | MEDLINE | ID: mdl-25480790

ABSTRACT

Oligomer formation and accumulation of pathogenic proteins are key events in the pathomechanisms of many neurodegenerative diseases, such as Alzheimer disease, ALS, and the polyglutamine (polyQ) diseases. The autophagy-lysosome degradation system may have therapeutic potential against these diseases because it can degrade even large oligomers. Although p62/sequestosome 1 plays a physiological role in selective autophagy of ubiquitinated proteins, whether p62 recognizes and degrades pathogenic proteins in neurodegenerative diseases has remained unclear. In this study, to elucidate the role of p62 in such pathogenic conditions in vivo, we used Drosophila models of neurodegenerative diseases. We found that p62 predominantly co-localizes with cytoplasmic polyQ protein aggregates in the MJDtr-Q78 polyQ disease model flies. Loss of p62 function resulted in significant exacerbation of eye degeneration in these flies. Immunohistochemical analyses revealed enhanced accumulation of cytoplasmic aggregates by p62 knockdown in the MJDtr-Q78 flies, similarly to knockdown of autophagy-related genes (Atgs). Knockdown of both p62 and Atgs did not show any additive effects in the MJDtr-Q78 flies, implying that p62 function is mediated by autophagy. Biochemical analyses showed that loss of p62 function delays the degradation of the MJDtr-Q78 protein, especially its oligomeric species. We also found that loss of p62 function exacerbates eye degeneration in another polyQ disease fly model as well as in ALS model flies. We therefore conclude that p62 plays a protective role against polyQ-induced neurodegeneration, by the autophagic degradation of polyQ protein oligomers in vivo, indicating its therapeutic potential for the polyQ diseases and possibly for other neurodegenerative diseases.


Subject(s)
Autophagy , Drosophila Proteins/metabolism , Neurodegenerative Diseases/metabolism , Peptides/chemistry , Photoreceptor Cells, Invertebrate/metabolism , TATA-Binding Protein Associated Factors/metabolism , Transcription Factor TFIID/metabolism , Animals , Cytoplasm/metabolism , Drosophila , Immunohistochemistry , Microscopy, Electron, Scanning , Phosphorylation , Photoreceptor Cells, Invertebrate/ultrastructure , Protein Denaturation , Protein Folding , Transgenes , Ubiquitinated Proteins/chemistry
15.
Front Neural Circuits ; 7: 191, 2013.
Article in English | MEDLINE | ID: mdl-24348341

ABSTRACT

Modulation of synapses under acute stress is attracting much attention. Exposure to acute stress induces corticosterone (CORT) secretion from the adrenal cortex, resulting in rapid increase of CORT levels in plasma and the hippocampus. We tried to test whether rapid CORT effects involve activation of essential kinases as non-genomic processes. We demonstrated rapid effects (~1 h) of CORT on the density of thorns, by imaging Lucifer Yellow-injected neurons in adult male rat hippocampal slices. Thorns of thorny excrescences of CA3 hippocampal neurons are post-synaptic regions whose presynaptic partners are mossy fiber terminals. The application of CORT at 100, 500, and 1000 nM induced a rapid increase in the density of thorns in the stratum lucidum of CA3 pyramidal neurons. Co-administration of RU486, an antagonist of glucocorticoid receptor (GR), abolished the effect of CORT. Blocking a single kinase, including MAPK, PKA, or PKC, suppressed CORT-induced enhancement of thorn-genesis. On the other hand, GSK-3ß was not involved in the signaling of thorn-genesis. Blocking AMPA receptors suppressed the CORT effect. Expression of CA3 synaptic/extranuclear GR was demonstrated by immunogold electron microscopic analysis. From these results, stress levels of CORT (100-1000 nM) might drive the rapid thorn-genesis via synaptic/extranuclear GR and multiple kinase pathways, although a role of nuclear GRs cannot be completely excluded.


Subject(s)
CA3 Region, Hippocampal/drug effects , Corticosterone/pharmacology , Dendritic Spines/drug effects , Neurons/drug effects , Receptors, Glucocorticoid/metabolism , Synapses/drug effects , Animals , CA3 Region, Hippocampal/metabolism , Dendritic Spines/metabolism , Hormone Antagonists/pharmacology , Male , Mifepristone/pharmacology , Neurons/metabolism , Rats , Rats, Wistar , Receptors, Glucocorticoid/antagonists & inhibitors , Synapses/metabolism
16.
Autophagy ; 9(8): 1167-71, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23839276

ABSTRACT

Lysosomes contain various hydrolases that can degrade proteins, lipids, nucleic acids and carbohydrates. We recently discovered "RNautophagy," an autophagic pathway in which RNA is directly taken up by lysosomes and degraded. A lysosomal membrane protein, LAMP2C, a splice variant of LAMP2, binds to RNA and acts as a receptor for this pathway. In the present study, we show that DNA is also directly taken up by lysosomes and degraded. Like RNautophagy, this autophagic pathway, which we term "DNautophagy," is dependent on ATP. The cytosolic sequence of LAMP2C also directly interacts with DNA, and LAMP2C functions as a receptor for DNautophagy, in addition to RNautophagy. Similarly to RNA, DNA binds to the cytosolic sequences of fly and nematode LAMP orthologs. Together with the findings of our previous study, our present findings suggest that RNautophagy and DNautophagy are evolutionarily conserved systems in Metazoa.


Subject(s)
DNA/metabolism , Lysosomes/metabolism , Animals , Cytosol/metabolism , Gene Knockout Techniques , HeLa Cells , Humans , Lysosomal-Associated Membrane Protein 2/metabolism , Mice , Mice, Inbred C57BL
17.
J Biol Chem ; 288(18): 12615-26, 2013 May 03.
Article in English | MEDLINE | ID: mdl-23543736

ABSTRACT

Dysregulation of cell proliferation and the cell cycle are associated with various diseases, such as cancer. Cyclin-dependent kinases (CDKs) play central roles in cell proliferation and the cell cycle. Ubiquitin C-terminal hydrolase L1 (UCH-L1) is expressed in a restricted range of tissues, including the brain and numerous types of cancer. However, the molecular functions of UCH-L1 remain elusive. In this study, we found that UCH-L1 physically interacts with CDK1, CDK4, and CDK5, enhancing their kinase activity. Using several mutants of UCH-L1, we showed that this enhancement is dependent upon interaction levels between UCH-L1 and CDKs but is independent of the known ubiquitin-related functions of UCH-L1. Gain- and loss-of-function studies revealed that UCH-L1 enhances proliferation of multiple cell types, including human cancer cells. Inhibition of the interaction between UCH-L1 and cell cycle-associated CDK resulted in the abolishment of UCH-L1-induced enhancement of cell proliferation. RNA interference of UCH-L1 reduced the growth of human xenograft tumors in mice. We concluded that UCH-L1 is a novel regulator of the kinase activities of CDKs. We believe that our findings from this study will significantly contribute to our understanding of cell cycle-associated diseases.


Subject(s)
CDC2 Protein Kinase/metabolism , Cell Proliferation , Cyclin-Dependent Kinase 4/metabolism , Cyclin-Dependent Kinase 5/metabolism , Neoplasm Proteins/metabolism , Neoplasms/enzymology , Ubiquitin Thiolesterase/metabolism , Animals , CDC2 Protein Kinase/genetics , COS Cells , Chlorocebus aethiops , Cyclin-Dependent Kinase 4/genetics , Cyclin-Dependent Kinase 5/genetics , HeLa Cells , Humans , Mice , Mutation , NIH 3T3 Cells , Neoplasm Proteins/genetics , Neoplasm Transplantation , Neoplasms/genetics , Neoplasms/pathology , Transplantation, Heterologous , Ubiquitin Thiolesterase/genetics
18.
Autophagy ; 9(3): 403-9, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23291500

ABSTRACT

Regulated degradation of cellular components by lysosomes is essential to maintain biological homeostasis. In mammals, three forms of autophagy, macroautophagy, microautophagy and chaperone-mediated autophagy (CMA), have been identified. Here, we showed a novel type of autophagy, in which RNA is taken up directly into lysosomes for degradation. This pathway, which we term "RNautophagy," is ATP-dependent, and unlike CMA, is independent of HSPA8/Hsc70. LAMP2C, a lysosomal membrane protein, serves as a receptor for this pathway. The cytosolic tail of LAMP2C specifically binds to almost all total RNA derived from mouse brain. The cytosolic sequence of LAMP2C and its affinity for RNA are evolutionarily conserved from nematodes to humans. Our findings shed light on the mechanisms underlying RNA homeostasis in higher eukaryotes.


Subject(s)
Autophagy , Lysosomes/metabolism , RNA/metabolism , Animals , Brain/embryology , Brain/metabolism , Conserved Sequence , HeLa Cells , Humans , Lysosomal-Associated Membrane Protein 2/metabolism , Mice , Mice, Knockout , Sequence Homology, Amino Acid
19.
PLoS One ; 7(4): e34124, 2012.
Article in English | MEDLINE | ID: mdl-22509272

ABSTRACT

BACKGROUND: Modulation of dendritic spines under acute stress is attracting much attention. Exposure to acute stress induces corticosterone (CORT) secretion from the adrenal cortex, resulting in rapid increase of CORT levels in plasma and the hippocampus. METHODOLOGY/PRINCIPAL FINDINGS: Here we demonstrated the mechanisms of rapid effect (∼1 h) of CORT on the density and morphology of spines by imaging neurons in adult male rat hippocampal slices. The application of CORT at 100-1000 nM induced a rapid increase in the density of spines of CA1 pyramidal neurons. The density of small-head spines (0.2-0.4 µm) was increased even at low CORT levels (100-200 nM). The density of middle-head spines (0.4-0.5 µm) was increased at high CORT levels between 400-1000 nM. The density of large-head spines (0.5-1.0 µm) was increased only at 1000 nM CORT. Co-administration of RU486, an antagonist of glucocorticoid receptor (GR), abolished the effect of CORT. Blocking a single kinase, such as MAPK, PKA, PKC or PI3K, suppressed CORT-induced enhancement of spinogenesis. Blocking NMDA receptors suppressed the CORT effect. CONCLUSIONS/SIGNIFICANCE: These results imply that stress levels of CORT (100-1000 nM) drive the spinogenesis via synaptic GR and multiple kinase pathways.


Subject(s)
CA1 Region, Hippocampal/drug effects , Corticosterone/pharmacology , Dendritic Spines/drug effects , Dendritic Spines/metabolism , Protein Kinases/metabolism , Receptors, Glucocorticoid/metabolism , Synapses/metabolism , Adrenalectomy , Animals , CA1 Region, Hippocampal/cytology , CA1 Region, Hippocampal/metabolism , CA1 Region, Hippocampal/physiology , Dose-Response Relationship, Drug , Excitatory Amino Acid Antagonists/pharmacology , In Vitro Techniques , Male , Protein Biosynthesis/drug effects , Rats , Rats, Wistar , Receptors, Glutamate/metabolism , Signal Transduction/drug effects , Stress, Physiological/drug effects , Synapses/drug effects , Time Factors
20.
J Steroid Biochem Mol Biol ; 131(1-2): 37-51, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22075082

ABSTRACT

The hippocampus synthesizes estrogen and androgen in addition to the circulating sex steroids. Synaptic modulation by hippocampus-derived estrogen or androgen is essential to maintain healthy memory processes. Rapid actions (1-2h) of 17ß-estradiol (17ß-E2) occur via synapse-localized receptors (ERα or ERß), while slow genomic E2 actions (6-48h) occur via classical nuclear receptors (ERα or ERß). The long-term potentiation (LTP), induced by strong tetanus or theta-burst stimulation, is not further enhanced by E2 perfusion in adult rats. Interestingly, E2 perfusion can rescue corticosterone (stress hormone)-induced suppression of LTP. The long-term depression is modulated rapidly by E2 perfusion. Elevation of the E2 concentration changes rapidly the density and head structure of spines in neurons. ERα, but not ERß, drives this enhancement of spinogenesis. Kinase networks are involved downstream of ERα. Testosterone (T) or dihydrotestosterone (DHT) also rapidly modulates spinogenesis. Newly developed Spiso-3D mathematical analysis is used to distinguish these complex effects by sex steroids and kinases. It has been doubted that the level of hippocampus-derived estrogen and androgen may not be high enough to modulate synaptic plasticity. Determination of the accurate concentration of E2, T or DHT in the hippocampus is enabled by mass-spectrometric analysis in combination with new steroid-derivatization methods. The E2 level in the hippocampus is approximately 8nM for the male and 0.5-2nM for the female, which is much higher than that in circulation. The level of T and DHT is also higher than that in circulation. Taken together, hippocampus-derived E2, T, and DHT play a major role in modulation of synaptic plasticity.


Subject(s)
Estradiol/physiology , Hippocampus/metabolism , Neuronal Plasticity , Testosterone/physiology , Animals , Dendritic Spines/drug effects , Dendritic Spines/physiology , Dihydrotestosterone/metabolism , Estrogen Receptor alpha/physiology , Estrogen Receptor beta/physiology , Female , Long-Term Potentiation/drug effects , Long-Term Synaptic Depression/drug effects , Male , Memory/drug effects , Memory/physiology , Neuronal Plasticity/drug effects , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...